Close Menu

NEW YORK — Healthcare company Centene said on Wednesday that it has signed an agreement to help distribute Quest Diagnostics SARS-CoV-2 test kits in the US.

According to St. Louis-based Centene, it will facilitate the distribution of 25,000 of Quest's rRT-PCR-based SARS-CoV-2 test kits each week to Federally Qualified Health Centers in 10 US states or districts, beginning on May 4. Centene said it will also provide oversight and training to ensure the test kits are received and processed properly.

Quest will perform the tests at its network laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.